Open Standard Industries, Inc. and the U.S. Army Medical Materiel Development Activity (USAMMDA) Announce Partnership to Submit OSR-M1 Face Mask for NIOSH Certification
Boston, Mass., April 7 2021: Open Standard Industries, Inc. (OSI), manufacturer of the OSR-M1 face mask, is pleased to formally announce they have entered into a Cooperative Research & Development Agreement (CRADA) with the U.S. Army Combat Capabilities Development Command, Chemical Biological Center (CBC) and the U.S. Army Medical Materiel Development Activity (USAMMDA). OSI intends to submit the OSR-M1 face mask to the National Institute for Occupational Safety and Health for certification as an N95 elastomeric half mask respirator.
In response to shortages in personal protective equipment as a result of the global coronavirus pandemic, the U.S. Government has played a leading role in ramping up production of certified respirators for healthcare and essential workers. In the fall of 2020, OSI entered into this joint CRADA with USAMMDA and CBC.
As part of the U.S. Army Medical Research and Development Command’s N95 Respirator Working Group, multiple prototypes have undergone testing at the CCDC-CBC. The OSR M1 is the first elastomeric half mask respirator to successfully pass this pre-NIOSH testing through a CRADA collaboration using this streamlined processes established by the Working Group.
As demonstrated in testing by the CCDC-CBC as well as other independent laboratories, the OSR-M1 mask filters provide >99% particulate filtration efficiency when tested against NIOSH standardized test procedures. The elastomeric materials used in the mask design produce an airtight seal, allowing the mask to fit securely on the wearer’s face and ensuring that any inhaled or exhaled air passes through the filter. The mask is also highly breathable, passing preliminary NIOSH tests of inhalation and exhalation resistance.
Dr. Matt Carney, CEO of Open Standard Industries, notes, “With these results from the CBC validating our earlier test data, I am confident in the performance of our mask and in our ability to take the next steps toward certification in collaboration with the Army.”
In addition to introducing new N95 respirators to the civilian and military markets, the CRADA may enable the USAMMDA to bolster the Department of Defense’s capability to manufacture protective respiratory devices. The Army has previously published efforts to 3D-print masks for prototyping respirators; the OSR-M1 is different, as it is produced through high-volume manufacturing processes, ensuring it can be rapidly and sustainably manufactured at scale in the USA while maintaining the quality control needed for medical-grade materials.
Maj Daniel Williams, Air Force Acquisition Fellow at the USAMMDA, states, “Collaborations with small business partners such as OSI, allows us to develop respirators for quality respiratory protection, both for future public health emergencies and military operations. This helps us to address the needs of the military and the general public.”
OSI and the USAMMDA intend to submit their joint application to NIOSH in March 2021.
About Open Standard Industries
Open Standard Industries, Inc., is committed to rapidly deploying and broadening access to safe, effective health technology. The OSR-M1 Mask is the company’s first product aimed at addressing the specific needs of frontline healthcare and essential workers. OSI is working in collaboration with various organizations and hospitals in the United States to test, validate, and scale mask production. OSI is a collaborative spinoff of the MIT Media Lab, Wake Forest Baptist Health, and multiple product development organizations.
About USAMMDA
USAMMDA is a subordinate command of the U.S. Army Medical Research and Development Command, under the Army Futures Command. As the premier developer of world-class military medical capabilities, USAMMDA is responsible for developing and delivering critical products designed to protect and preserve the lives of Warfighters across the globe. USAMRDC is leading research to prevent, detect and treat COVID-19. USAMMDA is applying existing field-leading research capabilities, a global research network and established partnerships to support the Whole-of-Government response to COVID-19.
About USACCDC CBC
The U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM Chemical Biological Center) is the primary Department of Defense technical organization for non-medical chemical and biological defense. DEVCOM Chemical Biological Center possesses an unrivaled chemical biological research and development infrastructure with scientists, engineers, technicians and specialists located at four different sites in the United States: Edgewood Area of Aberdeen Proving Ground, Md., Pine Bluff, Ark., Rock Island, Ill., and Dugway Proving Ground, Utah. DEVCOM Chemical Biological Center has a unique role in technology development that cannot be duplicated by private industry or research universities. It fosters research, development, testing, and application of technologies for protecting warfighters, first responders and the nation from chemical and biological warfare agents.
Click here for a PDF version of this press release.
]]>Open Standard Industries, Inc. Announces User Experience Study of OSR-M1 Face Mask at Wake Forest Baptist Health, Wake Forest School of Medicine
Boston, Mass., April 7 2021: Open Standard Industries, Inc. (OSI), manufacturer of the OSR-M1 non-valved reusable elastomeric face mask, is pleased to formally announce the launch of its first Institutional Review Board (IRB)-approved user feasibility study. The trial is being led by the departments of Biomedical Engineering and Infectious Diseases at Wake Forest School of Medicine, part of Wake Forest Baptist Health. Recruitment in the study is underway, and enrollment is expected to be completed by May 28, 2021.
Given mounting evidence of the airborne transmission and multiple variants of SARS-CoV-2, public health officials have advocated for improved respiratory personal protection equipment (PPE) that offers better protection over standard disposable masks, while being comfortable, reusable and easy to use.
A remote team led by Massachusetts Institute of Technology (MIT) alumnus Matt Carney, Ph.D., designed and prototyped the OSR-M1 in the spring of 2020. Wake Forest Baptist Health supported design, development, testing, and early manufacturing efforts, and has continued to be an active partner throughout the past year. Carney, Ph.D., CEO of OSI, comments, “Due to PPE supply constraints beginning in March of 2020, we set out to design a better mask for healthcare workers. The early input of clinicians, and health and safety managers was invaluable in designing the mask. We believe testing with the clinical staff at Wake Forest Baptist and Atrium Health will provide further verification of those efforts.”
The OSI team is currently submitting the mask to the National Institute of Occupational Safety and Health (NIOSH) aiming for certification as an N95 respirator. According to independent testing, OSR-M1’s design is already passing the necessary performance testing standards outlined in 42 CFR part 84 for elastomeric masks. The OSR-M1 mask filters more than 99% of airborne particles while being highly breathable, and easy to clean and re-use. The modular design of the OSR-M1 also uses on average four times less filter material than a disposable mask and pays for itself after 20-30 wears, making it ideal for large employers such as health systems which need to provide PPE to their staff.
For health systems in particular, creating a diversified supply of durable, reusable masks will be critical to ensuring a resilient response to the end of the coronavirus pandemic and to future public health crises.
Although the mass vaccine roll-outs this year have reduced transmission of SARS-Cov2, experts anticipate that masks will continue to be necessary until 2022. Werner Bischoff, M.D., Ph.D., co-principal investigator of the study and, professor of infectious diseases at Wake Forest School of Medicine remarks, “The SARS-CoV outbreak in 2002/4, the H1N1 Influenza pandemic in 2009/10, The MERS-CoV outbreak in 2012, and the ongoing SARS-CoV-2 pandemic also known as COVID-19 demonstrates the recurring risk of novel respiratory viruses to global health. Even with the highly accelerated development of vaccines the initial response to these threats relies solely on preventive measures such as social distancing, hand hygiene and respiratory personal protective equipment. Providing effective and reusable respiratory protection is an essential element of our current and future preventive strategies to successfully control and suppress virus transmission.”
Given the importance of fit to performance, the Wake Forest Baptist study will focus on evaluating face-fit across a large, diverse clinical population. According to OSI co-founder Philip Brown, Ph.D., co-principal investigator of the study and assistant professor of biomedical engineering at Wake Forest School of Medicine, “Clinicians struggle to achieve a good fit with disposable respirators. Without a good face seal employees do not get adequate protection against airborne pathogens. This user feasibility study will explore the potential benefits gained through elastomeric respirators to fit and protect a diverse clinical workforce.”
Conrad Emmerich, senior vice president of supply chain for Atrium Health, notes, “Even with the rollout of COVID-19 vaccines, we expect that respirators will continue to be used in a healthcare setting for an extended period of time. Safety of our health care workers is paramount, and we want to ensure we have a domestic source for a sustainable, diversified, resilient supply of PPE to best protect them now and into the future.”
About Open Standard Industries
Open Standard Industries, Inc., is committed to rapidly deploying and broadening access to safe, effective health technology. The OSR-M1 Mask is the company’s first product aimed at addressing the specific needs of frontline healthcare and essential workers. OSI is working in collaboration with various organizations and hospitals in the United States to test, validate, and scale mask production. OSI is a collaborative spinoff of the MIT Media Lab, Wake Forest Baptist Health, and multiple product development organizations.
About Wake Forest Baptist Health
Wake Forest Baptist Health is a pre-eminent academic health system, with more than 20,000 employees, based in Winston-Salem, North Carolina. Wake Forest Baptist’s two main components are an integrated clinical system – anchored by Wake Forest Baptist Medical Center, an 885-bed tertiary-care hospital in Winston-Salem – that includes Brenner Children’s Hospital, five community hospitals, more than 300 primary and specialty care locations and more than 2,500 physicians; and Wake Forest School of Medicine, a recognized leader in experiential medical education and groundbreaking research. Within the School of Medicine is the Department of Biomedical Engineering (BME), an engine of transformational research into medical understanding and technology. Biomedical Engineers use engineering principles to improve human health, and speak the language of medicine and engineering. They work hand-in-hand with physicians, government agencies such as the NIH, CDC, FDA, and others, and companies in health-related fields. The BME department is one of the prominent tracks within the graduate school with nearly one fourth of the graduate student population. BME has 11 primary faculty, 27 core faculty, and 47 affiliate faculty at WFU with about $20 million in research funding per year.
Click here for a PDF of this press release.
]]>